Description of the Business. The Company is a clinical stage pharmaceutical company focused on the development and commercialization of radiotherapeutics and theranostic products. The company will compete in all medical therapeutic categories.
Description of the Business. The Resident may conduct only the business described below.
a. Air Force Certified Child Care in a Child Development Home: (initial)
b. Other (description):
Description of the Business. The Company is a clinical stage pharmaceutical company focused on the development and commercialization of radiotherapeutics and theranostic products. The company will compete in all medical therapeutic categories. For the purposes of Restrictive Covenants as defined in Section 5.3, the company is in the Business related to the development of the following drug products and associated radioisotopes:
1. Lu177 radioisotope products
2. Tb161 radioisotope products
3. PSMA–I&T or similar prostate therapeutic drug products
4. DOTATATE or similar neuroendocrine therapeutic drug products
5. FAP or similar therapeutic drug products
6. GRP or similar therapeutic drug products
7. Other future specific drug products and radioisotope products entered into development by the company Employee agrees not to compete in these drug products and radioisotopes, and future specific drug products and radioisotope products as defined within the non-complete clauses of this agreement, sections 5.3.1 and 5.3.2. Exhibit 1.1.15 Invention Disclosure #1 Inventors: 1.Txxx X. Xxxxxxxxxx Title of Invention :Intellectual Property – Quality Management system Problem solved by invention: Self-evident Invention Description: Intellectual property consisting of procedures, policies, concepts, diagrams, record templates, work instructions, forms and similar written and electronic documentation that is the basis for a Quality Management System for the manufacturing of drug products in accordance with, but not limited to, 21 CFR 210,211,212 and ICH Q7,Q9, and Q10. Inventory Signature: /s/ Txxx Xxxxxxxxxx Date: April 23, 2020 Invention Disclosure #2 Inventors: 1. Txxx X. Xxxxxxxxxx Title of Invention: Intellectual Property – Radiation safety and RAM Licensing Program Problem solved by invention: Self-evident Invention Description: Intellectual property consisting of radioactive material and radiation safety documentation including, but not limited to, procedures, policies, concepts, diagrams, record templates, work instructions, forms and similar written and electronic documentation that is the basis for the development of Radioactive Material License Agreement State agencies, as well as the on going safe use and handling of radioactive material. Inventory Signature: /s/ Txxx Xxxxxxxxxx Date: April 23, 2020 The Executive Vice President, US Manufacturing Operations reports directly to the CEO and leads the design, construction, qualification/validation and operation of POINT Biopharma’s United State...
Description of the Business. The Company is a clinical stage pharmaceutical company focused on the development and commercialization of radiotherapeutics and theranostic products. The company will compete in therapeutic categories related to the use of radiotherapeutics and theranostic products in oncology. The Executive Vice President, Clinical Development reports directly to the CEO and leads all clinical development activities, including Managing Biostatistics & Programing, Data Management, Clinical Imaging, Clinical Operations, & Clinical Science to support clinical development activities in US and Canada, and may include jurisdictions in Europe and the rest of the world. In this role you will make strategic decisions to achieve the Company’s stated development, business and financial objectives. · Design, oversee and execute on clinical and regulatory strategy · Serve as the clinical lead in FDA meetings and Regulatory document preparation including Information Packages, Clinical Study Reports and clinical NDA content (e.g. ISS, SCS, ISE, SCE, SAP) · Oversee clinical research resourcing including consultants, CROs and other vendors to ensure optimization and effectiveness of clinical program deliverables within allocated budgets · Lead Investigator Meetings, Steering Committee and Advisory Board meetings to gain strategic input into study design, data analysis and patient/physician needs · Set and manage the annual clinical budget · Set the clinical development road map and associated budgets · Lead KOL engagement to incorporate current concepts and direction within clinical programs · Support commercialization and launch activities of product candidates · With the leadership team, create and deploy the Company’s vision and mission and short- and long-term objective and strategies · Develop high quality business strategies and plans ensuring their alignment with short-term and long-term objectives · Work with the leadership team to develop the corporate objectives to achieve the Company’s goals · Create an environment that promotes great performance and positive morale Maintain an awareness of the competitive market landscape, expansion opportunities and industry developments · Ensure that the Company maintains high social responsibility and ethics wherever it does business · Assess risks to the Company and ensures they are monitored and minimized Build alliances and partnerships with other organizations, key partners and stakeholders and act as a point of contact for important p...
Description of the Business. The Business sold hereby comprises all of the assets set forth herein below: XXXX ET ASSOCIES FINAL APRIL 24, 2003
Description of the Business. The Company is a development-stage pharmaceutical company focused on the development of oncology therapies or diagnostics based on targeting the N terminal domains of receptors including but not limited to the proprietary compounds named EPI-002 and EPI-506 as a treatment for advanced prostate cancer. In addition, the Company is engaged in the business of developing novel therapeutics for cancer, and therefore compounds or classes of compounds that are actively being developed by the Company will be identified and included in the description of the Business, which may be amended by the Company from time to time.
Description of the Business. Xtribe is a free application which geolocates products and services offered by private individuals and businesses in the vicinity of the user.
Description of the Business. With the exclusion of the items set out in section 2.2.3, the Business consists in the development, manufacture and distribution of the Products, as described in Schedule 2.2, for haematology laboratories and blood banks and comprises the following assets:
Description of the Business. The Company is a development-stage pharmaceutical company focused on a proprietary compound named EPI-506 as a treatment for advanced prostate cancer. EPI-506 was designed to block a novel target on the androgen receptor, the N-terminal domain. It is widely accepted that blocking the N-terminal domain of the androgen receptor has the potential to block tumor growth after current hormone-therapy drugs have failed.
Description of the Business
